Transient neonatal hypocalcemia: Presentation and outcomes

Teena C. Thomas, Joshua M. Smith, Perrin C. White, Soumya Adhikari

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVE: To determine the incidence of moderate-to-severe transient neonatal hypocalcemia in term neonates and to describe the characteristics of affected infants and the outcomes of their management. METHODS: We reviewed medical records of all term infants <31 days of age who presented to Children's Medical Center Dallas from 2001 to 2009 with hypocalcemia (ionized calcium <1.00 mmol/L [4.00 mg/dL]). RESULTS: Seventy-eight infants met criteria. Median (interquartile range) age at admission was 8.0 (7.0-10.0) days, and median duration of admission was 3.0 (2.0-4.0) days. Most infants were male (71.8%) and Hispanic (62.8%). Neonates were generally severely hypocalcemic and hyperphosphatemic. Seventy-five of 78 were hypomagnesemic, and the majority had low or inappropriately normal parathyroid hormone responses. Levels of 25-hydroxyvitamin D were ≤62.4 nmol/L (25 ng/mL) in all 42 infants in whom they were determined. All infants responded to therapy of limited duration with 1 or more of the following: calcium supplements, calcitriol, low phosphorus formula, and magnesium supplementation. Neuroimaging did not affect management decisions in any neonate. CONCLUSIONS: Moderate-to-severe late-onset neonatal hypocalcemia is more common in Hispanic and male infants, is often a sign of coexistent vitamin D insufficiency or deficiency and hypomagnesemia, and is readily managed with therapy of limited duration. Neonates presenting with seizures who are found to be hypocalcemic are unlikely to benefit from neuroimaging evaluations.

Original languageEnglish (US)
JournalPediatrics
Volume129
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Hypocalcemia
Newborn Infant
Hispanic Americans
Neuroimaging
Calcium
Avitaminosis
Calcitriol
Parathyroid Hormone
Vitamin D
Phosphorus
Magnesium
Medical Records
Seizures
Incidence
Therapeutics

Keywords

  • Calcium supplementation
  • DiGeorge syndrome
  • Parathyroid hormone disorders
  • Seizures (neonatal)
  • Vitamin D

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Arts and Humanities (miscellaneous)

Cite this

Transient neonatal hypocalcemia : Presentation and outcomes. / Thomas, Teena C.; Smith, Joshua M.; White, Perrin C.; Adhikari, Soumya.

In: Pediatrics, Vol. 129, No. 6, 06.2012.

Research output: Contribution to journalArticle

@article{24d0a02a8c574198bb3a48004b68a4ac,
title = "Transient neonatal hypocalcemia: Presentation and outcomes",
abstract = "OBJECTIVE: To determine the incidence of moderate-to-severe transient neonatal hypocalcemia in term neonates and to describe the characteristics of affected infants and the outcomes of their management. METHODS: We reviewed medical records of all term infants <31 days of age who presented to Children's Medical Center Dallas from 2001 to 2009 with hypocalcemia (ionized calcium <1.00 mmol/L [4.00 mg/dL]). RESULTS: Seventy-eight infants met criteria. Median (interquartile range) age at admission was 8.0 (7.0-10.0) days, and median duration of admission was 3.0 (2.0-4.0) days. Most infants were male (71.8{\%}) and Hispanic (62.8{\%}). Neonates were generally severely hypocalcemic and hyperphosphatemic. Seventy-five of 78 were hypomagnesemic, and the majority had low or inappropriately normal parathyroid hormone responses. Levels of 25-hydroxyvitamin D were ≤62.4 nmol/L (25 ng/mL) in all 42 infants in whom they were determined. All infants responded to therapy of limited duration with 1 or more of the following: calcium supplements, calcitriol, low phosphorus formula, and magnesium supplementation. Neuroimaging did not affect management decisions in any neonate. CONCLUSIONS: Moderate-to-severe late-onset neonatal hypocalcemia is more common in Hispanic and male infants, is often a sign of coexistent vitamin D insufficiency or deficiency and hypomagnesemia, and is readily managed with therapy of limited duration. Neonates presenting with seizures who are found to be hypocalcemic are unlikely to benefit from neuroimaging evaluations.",
keywords = "Calcium supplementation, DiGeorge syndrome, Parathyroid hormone disorders, Seizures (neonatal), Vitamin D",
author = "Thomas, {Teena C.} and Smith, {Joshua M.} and White, {Perrin C.} and Soumya Adhikari",
year = "2012",
month = "6",
doi = "10.1542/peds.2011-2659",
language = "English (US)",
volume = "129",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "6",

}

TY - JOUR

T1 - Transient neonatal hypocalcemia

T2 - Presentation and outcomes

AU - Thomas, Teena C.

AU - Smith, Joshua M.

AU - White, Perrin C.

AU - Adhikari, Soumya

PY - 2012/6

Y1 - 2012/6

N2 - OBJECTIVE: To determine the incidence of moderate-to-severe transient neonatal hypocalcemia in term neonates and to describe the characteristics of affected infants and the outcomes of their management. METHODS: We reviewed medical records of all term infants <31 days of age who presented to Children's Medical Center Dallas from 2001 to 2009 with hypocalcemia (ionized calcium <1.00 mmol/L [4.00 mg/dL]). RESULTS: Seventy-eight infants met criteria. Median (interquartile range) age at admission was 8.0 (7.0-10.0) days, and median duration of admission was 3.0 (2.0-4.0) days. Most infants were male (71.8%) and Hispanic (62.8%). Neonates were generally severely hypocalcemic and hyperphosphatemic. Seventy-five of 78 were hypomagnesemic, and the majority had low or inappropriately normal parathyroid hormone responses. Levels of 25-hydroxyvitamin D were ≤62.4 nmol/L (25 ng/mL) in all 42 infants in whom they were determined. All infants responded to therapy of limited duration with 1 or more of the following: calcium supplements, calcitriol, low phosphorus formula, and magnesium supplementation. Neuroimaging did not affect management decisions in any neonate. CONCLUSIONS: Moderate-to-severe late-onset neonatal hypocalcemia is more common in Hispanic and male infants, is often a sign of coexistent vitamin D insufficiency or deficiency and hypomagnesemia, and is readily managed with therapy of limited duration. Neonates presenting with seizures who are found to be hypocalcemic are unlikely to benefit from neuroimaging evaluations.

AB - OBJECTIVE: To determine the incidence of moderate-to-severe transient neonatal hypocalcemia in term neonates and to describe the characteristics of affected infants and the outcomes of their management. METHODS: We reviewed medical records of all term infants <31 days of age who presented to Children's Medical Center Dallas from 2001 to 2009 with hypocalcemia (ionized calcium <1.00 mmol/L [4.00 mg/dL]). RESULTS: Seventy-eight infants met criteria. Median (interquartile range) age at admission was 8.0 (7.0-10.0) days, and median duration of admission was 3.0 (2.0-4.0) days. Most infants were male (71.8%) and Hispanic (62.8%). Neonates were generally severely hypocalcemic and hyperphosphatemic. Seventy-five of 78 were hypomagnesemic, and the majority had low or inappropriately normal parathyroid hormone responses. Levels of 25-hydroxyvitamin D were ≤62.4 nmol/L (25 ng/mL) in all 42 infants in whom they were determined. All infants responded to therapy of limited duration with 1 or more of the following: calcium supplements, calcitriol, low phosphorus formula, and magnesium supplementation. Neuroimaging did not affect management decisions in any neonate. CONCLUSIONS: Moderate-to-severe late-onset neonatal hypocalcemia is more common in Hispanic and male infants, is often a sign of coexistent vitamin D insufficiency or deficiency and hypomagnesemia, and is readily managed with therapy of limited duration. Neonates presenting with seizures who are found to be hypocalcemic are unlikely to benefit from neuroimaging evaluations.

KW - Calcium supplementation

KW - DiGeorge syndrome

KW - Parathyroid hormone disorders

KW - Seizures (neonatal)

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84861910403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861910403&partnerID=8YFLogxK

U2 - 10.1542/peds.2011-2659

DO - 10.1542/peds.2011-2659

M3 - Article

C2 - 22614771

AN - SCOPUS:84861910403

VL - 129

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 6

ER -